core scientific inc - CORZ

CORZ

Close Chg Chg %
18.73 -0.85 -4.51%

Open Market

17.89

-0.85 (4.51%)

Volume: 3.09M

Last Updated:

Sep 9, 2026, 12:20 PM EDT

Company Overview: core scientific inc - CORZ

CORZ Key Data

Open

$18.75

Day Range

17.87 - 18.95

52 Week Range

13.36 - 30.46

Market Cap

$5.75B

Shares Outstanding

321.34M

Public Float

306.91M

Beta

5.48

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$4.24

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

11.63M

 

CORZ Performance

1 Week
 
4.70%
 
1 Month
 
-10.85%
 
3 Months
 
-32.14%
 
1 Year
 
18.10%
 
5 Years
 
N/A
 

CORZ Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 18
Full Ratings ➔

About core scientific inc - CORZ

Core Scientific, Inc. engages in the business of operating a purpose-built facility for digital asset mining and provision of blockchain infrastructure, software solutions, and services. It operates under the Mining and Hosting segments. The Mining segment focuses on bitcoin mining for the company's own account. The Hosting segment includes blockchain infrastructure and third-party hosting business. The company was founded by Michael Jeffrey Levitt and Darin Feinstein on December 13, 2017 and is headquartered in Dover, DE.

CORZ At a Glance

Core Scientific, Inc.
838 Walker Road
Dover, Delaware 19904
Phone 1-512-402-5233 Revenue 319.02M
Industry Packaged Software Net Income -280,740,000.00
Sector Technology Services Employees 325
Fiscal Year-end 12 / 2026
View SEC Filings

CORZ Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 14.517
Price to Book Ratio N/A
Price to Cash Flow Ratio 16.64
Enterprise Value to EBITDA -48.615
Enterprise Value to Sales 17.185
Total Debt to Enterprise Value 0.212

CORZ Efficiency

Revenue/Employee 981,596.923
Income Per Employee -863,815.385
Receivables Turnover 0.945
Total Asset Turnover 0.16

CORZ Liquidity

Current Ratio 1.146
Quick Ratio 1.146
Cash Ratio 0.398

CORZ Profitability

Gross Margin 11.532
Operating Margin -60.481
Pretax Margin -90.287
Net Margin -88.001
Return on Assets -14.121
Return on Equity N/A
Return on Total Capital -140.522
Return on Invested Capital -104.152

CORZ Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital 581.893
Total Debt to Total Assets 48.897
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital 575.715
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Core Scientific Inc - CORZ

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
640.31M 502.40M 510.67M 319.02M
Sales Growth
- -21.54% +1.65% -37.53%
Cost of Goods Sold (COGS) incl D&A
631.91M 427.16M 389.60M 282.23M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
226.09M 96.44M 120.12M 80.18M
Depreciation
223.60M 95.70M 112.30M 79.37M
Amortization of Intangibles
2.49M 745.00K 7.82M 813.00K
COGS Growth
- -32.40% -8.79% -27.56%
Gross Income
8.40M 75.24M 121.07M 36.79M
Gross Income Growth
- +795.67% +60.92% -69.61%
Gross Profit Margin
+1.31% +14.98% +23.71% +11.53%
2022 2023 2024 2025 5-year trend
SG&A Expense
252.97M 59.89M 132.25M 229.74M
Research & Development
- 26.96M 7.18M 11.83M
Other SG&A
226.01M 52.70M 120.42M 229.74M
SGA Growth
+4,945.34% -76.33% +120.82% +73.72%
Other Operating Expense
- - - -
-
Unusual Expense
1.83B 179.38M 1.26B 88.64M
EBIT after Unusual Expense
(2.08B) (164.03M) (1.27B) (281.59M)
Non Operating Income/Expense
11.04M 4.47M (4.94M) (6.44M)
Non-Operating Interest Income
- - - 3.28M
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- 96.83M 86.24M 37.07M
Interest Expense Growth
- - -10.94% -57.01%
-
Gross Interest Expense
- 96.83M 86.24M 37.07M
Interest Capitalized
- - - -
-
Pretax Income
(2.16B) (245.80M) (1.31B) (288.03M)
Pretax Income Growth
-6,556.94% +88.64% -434.63% +78.08%
Pretax Margin
-337.87% -48.93% -257.34% -90.29%
Income Tax
(17.09M) 683.00K 859.00K 583.00K
Income Tax - Current - Domestic
1.43M 683.00K 859.00K 583.00K
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- - - (18.52M)
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - 192.59M 7.88M
-
Consolidated Net Income
(2.15B) (246.49M) (1.12B) (280.74M)
Minority Interest Expense
- - - -
-
Net Income
(2.15B) (246.49M) (1.12B) (280.74M)
Net Income Growth
-6,504.35% +88.52% -355.37% +74.99%
Net Margin Growth
-335.20% -49.06% -219.79% -88.00%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(2.15B) (246.49M) (1.12B) (280.74M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(2.15B) (246.49M) (1.12B) (280.74M)
EPS (Basic)
-6.3007 -0.6489 -4.3873 -0.8826
EPS (Basic) Growth
-736.08% +89.70% -576.11% +79.88%
Basic Shares Outstanding
340.65M 379.86M 255.83M 318.07M
EPS (Diluted)
-6.3007 -0.6489 -4.3873 -0.8826
EPS (Diluted) Growth
-736.08% +89.70% -576.11% +79.88%
Diluted Shares Outstanding
340.65M 379.86M 255.83M 318.07M
EBITDA
(18.48M) 111.79M 108.94M (112.77M)
EBITDA Growth
-254.46% +704.94% -2.55% -203.51%
EBITDA Margin
-2.89% +22.25% +21.33% -35.35%

Snapshot

Average Recommendation BUY Average Target Price 36.706
Number of Ratings 18 Current Quarters Estimate -0.018
FY Report Date 09 / 2026 Current Year's Estimate -4.495
Last Quarter’s Earnings -3.32 Median PE on CY Estimate N/A
Year Ago Earnings -0.88 Next Fiscal Year Estimate 0.295
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 13 13 12 14
Mean Estimate -0.02 -0.01 -4.49 0.30
High Estimates 0.18 0.19 -3.30 1.46
Low Estimate -0.32 -0.38 -5.29 -1.41
Coefficient of Variance -660.55 -1,213.36 -10.66 284.97

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 16 16 15
OVERWEIGHT 1 1 2
HOLD 1 1 2
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Insider Actions for Core Scientific Inc - CORZ

Date Name Shares Transaction Value
Aug 27, 2026 Todd Michael DuChene See remarks 1,937,896 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $17.45 per share 33,816,285.20
Apr 16, 2026 Todd Michael DuChene See remarks 2,027,089 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $18.99 per share 38,494,420.11
Jan 27, 2026 Adam Sullivan Chief Executive Officer; Director 4,131,300 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $18.79 per share 77,627,127.00

Core Scientific Inc in the News